Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content
Fig. 3 | Journal of Cannabis Research

Fig. 3

From: A potential role for cannabichromene in modulating TRP channels during acute respiratory distress syndrome

Fig. 3

Inhalant cannabichromene (CBC) reduced ARDS-like induced inflammatory indices. Flow cytometry analysis of A whole blood and B lung tissues showed that Intranasal administration of Poly(I:C) effectuated a significant increase of pro-inflammatory cytokines including IL-6, IL-17, and IFNγ (PIC group) compared to the control group (sham). These effects were reversed with inhalant CBC (PIC + CBC), resulted in marked downregulation of all three pro-inflammatory cytokines (*p<0.03, means +/− SD). Further, the flow cytometry analysis of whole blood in the PIC group showed increased granulocytes (G) and monocytes (M) while lymphocytes were decreased compared to mice treated with inhalant CBC (PIC + CBC) supporting the notion that inhalant CBC can reverse the adverse effects of ARDS and re-establish the immune balance, resolving lymphopenia and restoring homeostasis

Back to article page

Journal of Cannabis Research

ISSN: 2522-5782